Yingfen Wu

1.9k total citations · 2 hit papers
12 papers, 1.3k citations indexed

About

Yingfen Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yingfen Wu has authored 12 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yingfen Wu's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Viral-associated cancers and disorders (3 papers). Yingfen Wu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Viral-associated cancers and disorders (3 papers). Yingfen Wu collaborates with scholars based in China, United States and Saudi Arabia. Yingfen Wu's co-authors include Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Xiayu Li, Xiaoling Li, Chunmei Fan, Can Guo, Fang Xiong, Bo Xiang and Ke Jin and has published in prestigious journals such as The FASEB Journal, British Journal of Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

Yingfen Wu

12 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities

2018 430 citations Yazhuo Zhang, Ke Jin et al. Molecular Cancer profile →
Role of metabolism in cancer cell radioresistance and radiosensitization methods

2018 308 citations Le Tang, Fang Wei et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yingfen Wu China	12	844	616	361	180	162	12	1.3k
Zhaoqing Tang China	18	1.1k 1.3×	529 0.9×	396 1.1×	194 1.1×	253 1.6×	45	1.5k
Mengjun Wang United States	20	900 1.1×	355 0.6×	236 0.7×	158 0.9×	259 1.6×	52	1.4k
Yi Jer Tan China	13	694 0.8×	260 0.4×	373 1.0×	163 0.9×	190 1.2×	24	1.4k
Miriam Redrado Spain	20	544 0.6×	270 0.4×	518 1.4×	177 1.0×	233 1.4×	39	1.1k
Wen-Hui Su Taiwan	14	471 0.6×	315 0.5×	270 0.7×	132 0.7×	106 0.7×	23	919
Takaaki Masuda Japan	25	1.1k 1.4×	775 1.3×	603 1.7×	397 2.2×	212 1.3×	102	2.0k
Marc Abrams United States	22	1.1k 1.3×	236 0.4×	281 0.8×	105 0.6×	163 1.0×	41	1.6k
Daniel C. Rabe United States	14	637 0.8×	270 0.4×	366 1.0×	240 1.3×	163 1.0×	24	1.2k
Jeff X. Zhou China	18	581 0.7×	165 0.3×	312 0.9×	142 0.8×	214 1.3×	35	1.3k
Lo‐Kong Chan Hong Kong	24	1.2k 1.4×	794 1.3×	486 1.3×	238 1.3×	262 1.6×	42	1.9k

Countries citing papers authored by Yingfen Wu

Since Specialization

Citations

This map shows the geographic impact of Yingfen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingfen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingfen Wu more than expected).

Fields of papers citing papers by Yingfen Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingfen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingfen Wu. The network helps show where Yingfen Wu may publish in the future.

Co-authorship network of co-authors of Yingfen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingfen Wu. A scholar is included among the top collaborators of Yingfen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingfen Wu. Yingfen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Wang, Dan, Le Tang, Yingfen Wu, et al.. (2020). Abnormal X chromosome inactivation and tumor development. Cellular and Molecular Life Sciences. 77(15). 2949–2958. 31 indexed citations

2.

Wu, Yingfen, Dan Wang, Wei Fang, et al.. (2020). EBV‐miR‐BART12 accelerates migration and invasion in EBV‐associated cancer cells by targeting tubulin polymerization‐promoting protein 1. The FASEB Journal. 34(12). 16205–16223. 25 indexed citations

3.

Wang, Dan, Zhaoyang Zeng, Shanshan Zhang, et al.. (2020). Epstein‐Barr virus‐encoded miR‐BART6‐3p inhibits cancer cell proliferation through the LOC553103‐STMN1 axis. The FASEB Journal. 34(6). 8012–8027. 38 indexed citations

4.

Fang, Wei, Yi He, Yanyan Tang, et al.. (2019). Cloning and characterization of the putative AFAP1-AS1 promoter region. Journal of Cancer. 10(5). 1145–1153. 23 indexed citations

5.

Wu, Yingfen, Wei Fang, Le Tang, et al.. (2019). Herpesvirus acts with the cytoskeleton and promotes cancer progression. Journal of Cancer. 10(10). 2185–2193. 30 indexed citations

6.

Fang, Wei, Le Tang, Yi He, et al.. (2018). BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression. Cell Death and Disease. 9(4). 432–432. 71 indexed citations

7.

Tang, Le, Fang Wei, Yingfen Wu, et al.. (2018). Role of metabolism in cancer cell radioresistance and radiosensitization methods. Journal of Experimental & Clinical Cancer Research. 37(1). 87–87. 308 indexed citations breakdown →

8.

Zhang, Yazhuo, Ke Jin, Shufei Wang, et al.. (2018). Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Molecular Cancer. 17(1). 45–45. 430 indexed citations breakdown →

9.

Tang, Yanyan, Jinpeng Wang, Yu Lian, et al.. (2017). Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer. Molecular Cancer. 16(1). 42–42. 115 indexed citations

10.

Fang, Wei, Yingfen Wu, Le Tang, et al.. (2017). BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM. British Journal of Cancer. 118(2). 233–247. 72 indexed citations

11.

Wei, Fang, Yingfen Wu, Le Tang, et al.. (2017). Trend analysis of cancer incidence and mortality in China. Science China Life Sciences. 60(11). 1271–1275. 51 indexed citations

12.

He, Baoyu, Wei‐Ming Li, Yingfen Wu, et al.. (2016). Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death and Disease. 7(9). e2353–e2353. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact